摘要 |
The present invention is a crystalline modification which is a novel crystalline form of N-(2-(3-phenylureido)phenyl)benzenesulfonamide, and is characterized by an X-ray diffraction pattern, obtained by powder X-ray diffractometry using Cu-Kα radiation, having peaks at of 23.60 degrees, 20.80 degrees, 12.24 degrees, and 13.80 degrees in diffraction angles (2θ ± 0.1 degrees). |